Literature DB >> 21753766

Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).

Nijiro Nohata1, Toyoyuki Hanazawa, Naoko Kikkawa, Muradil Mutallip, Daiju Sakurai, Lisa Fujimura, Kazumori Kawakami, Takeshi Chiyomaru, Hirofumi Yoshino, Hideki Enokida, Masayuki Nakagawa, Yoshitaka Okamoto, Naohiko Seki.   

Abstract

Our microRNA (miRNA) expression signatures of hypopharyngeal squamous cell carcinoma, maxillary sinus squamous cell carcinoma and esophageal squamous cell carcinoma revealed that miR-375 was significantly reduced in cancer tissues compared with normal epithelium. In this study, we focused on the functional significance of miR-375 in cancer cells and identification of miR-375-regulated novel cancer networks in head and neck squamous cell carcinoma (HNSCC). Restoration of miR-375 showed significant inhibition of cell proliferation and induction of cell apoptosis in SAS and FaDu cell lines, suggesting that miR-375 functions as a tumor suppressor. We adopted genome-wide gene expression analysis to search for miR-375-regulated molecular targets. Gene expression data and luciferase reporter assays revealed that AEG-1/MTDH was directly regulated by miR-375. Cancer cell proliferation was significantly inhibited in HNSCC cells transfected with si-AEG-1/MTDH. In addition, expression levels of AEG-1/MTDH were significantly upregulated in cancer tissues. Therefore, AEG-1/MTDH may function as an oncogene in HNSCC. The identification of novel tumor suppressive miRNA and its regulated cancer pathways could provide new insights into potential molecular mechanisms of HNSCC oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21753766     DOI: 10.1038/jhg.2011.66

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  49 in total

Review 1.  The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.

Authors:  Evan K Noch; Kamel Khalili
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

2.  Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Ryosuke Matsushita; Hiroko Mataki; Keiko Mizuno; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-05-12       Impact factor: 3.172

3.  MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.

Authors:  Lizandra Jimenez; Ved P Sharma; John Condeelis; Thomas Harris; Thomas J Ow; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Arch Pathol Lab Med       Date:  2015-07-14       Impact factor: 5.534

Review 4.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

5.  Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma.

Authors:  Yichao Wang; Xiaolin Wang; Yu Zhang; Lan Yu; Bo Zhu; Shiwu Wu; Danna Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 6.  AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression.

Authors:  Seok-Geun Lee; Dong-Chul Kang; Rob DeSalle; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 7.  Drug resistance mediated by AEG-1/MTDH/LYRIC.

Authors:  Xiangbing Meng; Kristina W Thiel; Kimberly K Leslie
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 8.  AEG-1/MTDH/LYRIC: clinical significance.

Authors:  Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 9.  The role of MTDH/AEG-1 in the progression of cancer.

Authors:  Xue Shi; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

10.  SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells.

Authors:  Sungguan Hong; Hyangsoon Noh; Yong Teng; Jing Shao; Hina Rehmani; Han-Fei Ding; Zheng Dong; Shi-Bing Su; Huidong Shi; Jaejik Kim; Shuang Huang
Journal:  Neoplasia       Date:  2014-04-18       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.